Cirsium Biosciences
Cirsium Biosciences is dedicated to revolutionizing gene therapy manufacturing by utilizing plant-based bioreactors and cutting-edge technology to produce high-quality viral vectors efficiently and cost-effectively. Their mission is to improve global access to life-saving gene therapies through innovative and scalable solutions.
Industries
health-care
manufacturing
medical-device
therapeutics
Nr. of Employees
small (1-50)
Cirsium Biosciences
Services
Plant-based AAV vector manufacturing platform (end-to-end)
End-to-end platform services covering AAV construct design and validation, transient plant expression (agroinfiltration), extraction/clarification, and downstream purification with a segregated upstream non-GMP and downstream GMP workflow.
Plant-based AAV vector manufacturing platform (end-to-end)
End-to-end platform services covering AAV construct design and validation, transient plant expression (agroinfiltration), extraction/clarification, and downstream purification with a segregated upstream non-GMP and downstream GMP workflow.
Expertise Areas
- Plant-based viral vector manufacturing
- AAV construct design and validation
- Transient plant expression systems (agroinfiltration)
- Controlled environment agriculture for biomanufacturing
Key Technologies
- AAV (adeno-associated virus) vector production
- Transient expression via agroinfiltration
- Controlled Environment Agriculture (CEA)
- Plasmid-based helper systems for plants